XML 35 R25.htm IDEA: XBRL DOCUMENT
v3.25.3

Equity - contributed equity | 12 Months Ended
--- | ---
Jun. 30, 2025
Disclosure [Abstract] |
Equity - contributed equity | Note 18. Equity - contributed equity
|  | 2025 |  |  | 2024 |  |  | 2023 |  |  | 2025 |  |  | 2024 |  |  | 2023 |
|  | Shares |  |  | Shares |  |  | Shares |  |  | A$‘000 |  |  | A$‘000 |  |  | A$‘000 |
Ordinary shares - fully paid |  |  | 809,418,734 |  |  |  | 332,850,784 |  |  |  | 228,029,114 |  |  |  | 123,046 |  |  |  | 101,638 |  |  |  | 97,452 |
Movements in ordinary share capital
Details |  | Date |  | Shares |  |  | Issue price |  |  | A$ |
Balance |  | 1 July 2022 |  |  | 138,755,376 |  |  |  |  |  |  |  | 84,480,249 |
ATM issue of shares No. 8 |  | 7 July 2022 |  |  | 573,370 |  |  | $ | 0.71 |  |  |  | 407,201 |
ATM issue of shares No. 9 |  | 8 August 2022 |  |  | 8,561,490 |  |  | $ | 0.33 |  |  |  | 2,839,346 |
ATM issue of shares No. 10 |  | 9 August 2022 |  |  | 10,000 |  |  | $ | 0.27 |  |  |  | 2,723 |
ATM issue of shares No. 11 |  | 10 August 2022 |  |  | 158,020 |  |  | $ | 0.25 |  |  |  | 38,949 |
ATM issue of shares No. 12 |  | 11 August 2022 |  |  | 330,960 |  |  | $ | 0.24 |  |  |  | 79,868 |
ATM issue of shares No. 13 |  | 12 August 2022 |  |  | 1,247,440 |  |  | $ | 0.25 |  |  |  | 308,050 |
ATM issue of shares No. 14 |  | 12 September 2022 |  |  | 651,030 |  |  | $ | 0.22 |  |  |  | 143,964 |
ATM issue of shares No. 15 |  | 13 September 2022 |  |  | 28,350 |  |  | $ | 0.22 |  |  |  | 6,200 |
Shares issued to Scientific Advisory Board |  | 14 September 2022 |  |  | 60,000 |  |  | $ | 0.21 |  |  |  | 12,600 |
ATM issue of shares No. 16 |  | 7 October 2022 |  |  | 736,760 |  |  | $ | 0.18 |  |  |  | 131,797 |
ATM issue of shares No. 17 |  | 28 October 2022 |  |  | 12,296,180 |  |  | $ | 0.19 |  |  |  | 2,293,288 |
ATM issue of shares No. 18 |  | 11 January 2023 |  |  | 20,000 |  |  | $ | 0.14 |  |  |  | 2,761 |
Professional and sophisticated investors placement - 1st tranche |  | 16 January 2023 |  |  | 25,387,018 |  |  | $ | 0.11 |  |  |  | 2,792,572 |
Professional and sophisticated investors placement - 2nd tranche |  | 28 February 2023 |  |  | 15,522,075 |  |  | $ | 0.11 |  |  |  | 1,707,428 |
Share Placement Plan |  | 3 March 2023 |  |  | 23,691,045 |  |  | $ | 0.11 |  |  |  | 2,606,000 |
Less: share issue transaction costs |  |  |  |  |  |  |  |  |  |  |  |  | (400,750 | )
Balance |  | 30 June 2023 |  |  | 228,029,114 |  |  |  |  |  |  |  | 97,452,246 |
Balance |  | 01 July 2023 |  |  | 228,029,114 |  |  |  |  |  |  |  | 97,452,246 |
ATM issue of shares No. 19 |  | 06 July 2023 |  |  | 8,148,140 |  |  | $ | 0.19 |  |  |  | 1,512,523 |
ATM issue of shares No. 20 |  | 07 July 2023 |  |  | 157,120 |  |  | $ | 0.16 |  |  |  | 25,877 |
ATM issue of shares No. 21 |  | 03 August 2023 |  |  | 15,000 |  |  | $ | 0.17 |  |  |  | 2,519 |
ATM issue of shares No. 22 |  | 29 November 2023 |  |  | 1,066,070 |  |  | $ | 0.10 |  |  |  | 107,268 |
Registered Direct Offering |  | 05 December 2023 |  |  | 26,200,000 |  |  | $ | — |  |  |  | — |
ATM issue of shares No. 23 |  | 13 February 2024 |  |  | 25,910 |  |  | $ | 0.05 |  |  |  | 1,207 |
ATM issue of shares No. 24 |  | 14 February 2024 |  |  | 319,650 |  |  | $ | 0.05 |  |  |  | 14,834 |
ATM issue of shares No. 25 |  | 15 February 2024 |  |  | 2,195,980 |  |  | $ | 0.05 |  |  |  | 102,825 |
ATM issue of shares No. 26 |  | 16 February 2024 |  |  | 205,260 |  |  | $ | 0.06 |  |  |  | 12,597 |
Armistice warrants |  | 21 February 2024 |  |  | 18,244,450 |  |  | $ | 0.05 |  |  |  | 892,655 |
ATM issue of shares No. 27 |  | 21 February 2024 |  |  | 8,626,580 |  |  | $ | 0.06 |  |  |  | 513,584 |
ATM issue of shares No. 28 |  | 22 February 2024 |  |  | 316,540 |  |  | $ | 0.05 |  |  |  | 14,584 |
ATM issue of shares No. 29 |  | 23 February 2024 |  |  | 304,860 |  |  | $ | 0.05 |  |  |  | 14,147 |
ATM issue of shares No. 30 |  | 26 February 2024 |  |  | 250,000 |  |  | $ | 0.05 |  |  |  | 11,502 |
ATM issue of shares No. 31 |  | 01 May 2024 |  |  | 2,112,560 |  |  | $ | 0.05 |  |  |  | 100,961 |
ATM issue of shares No. 32 |  | 02 May 2024 |  |  | 375,410 |  |  | $ | 0.05 |  |  |  | 17,147 |
ATM issue of shares No. 33 |  | 03 May 2024 |  |  | 288,900 |  |  | $ | 0.05 |  |  |  | 13,544 |
ATM issue of shares No. 34 |  | 07 May 2024 |  |  | 790,100 |  |  | $ | 0.05 |  |  |  | 36,024 |
ATM issue of shares No. 35 |  | 10 May 2024 |  |  | 20,000 |  |  | $ | 0.05 |  |  |  | 910 |
ATM issue of shares No. 36 |  | 16 May 2024 |  |  | 242,170 |  |  | $ | 0.05 |  |  |  | 10,891 |
Repayment of promissory note |  | 19 June 2024 |  |  | 5,916,970 |  |  | $ | 0.06 |  |  |  | 380,223 |
Equity line of credit |  | 24 June 2024 |  |  | 29,000,000 |  |  | $ | 0.03 |  |  |  | 776,264 |
Less: share issue transaction costs |  |  |  |  |  |  |  |  |  |  |  |  | (376,573 | )
Balance |  | 30 June 2024 |  |  | 332,850,784 |  |  |  |  |  |  |  | 101,637,758 |
Balance |  | 30 June 2024 |  |  | 332,850,784 |  |  |  |  |  |  |  | 101,637,758 |
Conversion of Warrants exercised |  | 11 July 2024 |  |  | — |  |  | $ | — |  |  |  | 6,459,830 |
Cancellation of convertible note shares |  | 02 July 2024 |  |  | (5,916,970 | ) |  | $ | — |  |  |  | (380,224 | )
ATM issue of shares No. 37 |  | 12 July 2024 |  |  | 14,400,000 |  |  | $ | 0.15 |  |  |  | 2,209,677 |
Alumni warrants shares issued |  | 11 July 2024 |  |  | 25,786,480 |  |  | $ | 0.29 |  |  |  | 739,536 |
Armistice warrants shares issued |  | 11 July 2024 |  |  | 11,000,000 |  |  | $ | 0.04 |  |  |  | 438,571 |
ATM issue of shares No. 38 |  | 15 July 2024 |  |  | 5,488,230 |  |  | $ | 0.14 |  |  |  | 792,915 |
ATM issue of shares No. 39 |  | 16 July 2024 |  |  | 4,177,340 |  |  | $ | 0.11 |  |  |  | 449,260 |
Alumni Equity Line of Credit |  | 18 July 2024 |  |  | 15,000,000 |  |  | $ | 0.05 |  |  |  | 816,373 |
ATM issue of shares No. 40 |  | 09 August 2024 |  |  | 2,061,820 |  |  | $ | 0.06 |  |  |  | 128,633 |
ATM issue of shares No. 41 |  | 13 August 2024 |  |  | 408,270 |  |  | $ | 0.06 |  |  |  | 26,172 |
ATM issue of shares No. 42 |  | 14 August 2024 |  |  | 2,283,350 |  |  | $ | 0.06 |  |  |  | 140,884 |
ATM issue of shares No. 43 |  | 15 August 2024 |  |  | 8,660 |  |  | $ | 0.06 |  |  |  | 525 |
ATM issue of shares No. 44 |  | 28 August 2024 |  |  | 5,250,000 |  |  | $ | 0.06 |  |  |  | 323,403 |
ATM issue of shares No. 45 |  | 29 August 2024 |  |  | 308,700 |  |  | $ | 0.06 |  |  |  | 18,242 |
ATM issue of shares No. 46 |  | 03 September 2024 |  |  | 3,000,000 |  |  | $ | 0.06 |  |  |  | 184,690 |
ATM issue of shares No. 47 |  | 04 September 2024 |  |  | 837,030 |  |  | $ | 0.06 |  |  |  | 53,439 |
ATM issue of shares No. 48 |  | 13 September 2024 |  |  | 16,049,020 |  |  | $ | 0.06 |  |  |  | 889,682 |
ATM issue of shares No. 49 |  | 14 September 2024 |  |  | 2,503,820 |  |  | $ | 0.05 |  |  |  | 130,741 |
ATM issue of shares No. 50 |  | 25 November 2024 |  |  | 442,400 |  |  | $ | 0.09 |  |  |  | 39,420 |
ATM issue of shares No. 51 |  | 26 November 2024 |  |  | 185,100 |  |  | $ | 0.09 |  |  |  | 16,312 |
Alumni Equity Line of Credit |  | 09 December 2024 |  |  | 15,000,000 |  |  | $ | 0.05 |  |  |  | 804,869 |
ATM issue of shares No. 52 |  | 27 November 2024 |  |  | 262,200 |  |  | $ | 0.08 |  |  |  | 22,239 |
ATM issue of shares No. 53 |  | 29 November 2024 |  |  | 896,700 |  |  | $ | 0.09 |  |  |  | 76,970 |
ATM issue of shares No. 54 |  | 02 December 2024 |  |  | 364,700 |  |  | $ | 0.08 |  |  |  | 29,832 |
ATM issue of shares No. 55 |  | 03 December 2024 |  |  | 2,926,100 |  |  | $ | 0.08 |  |  |  | 227,709 |
ATM issue of shares No. 56 |  | 04 December 2024 |  |  | 403,300 |  |  | $ | 0.08 |  |  |  | 31,753 |
ATM issue of shares No. 57 |  | 05 December 2024 |  |  | 460,800 |  |  | $ | 0.08 |  |  |  | 36,011 |
ATM issue of shares No. 58 |  | 10 December 2024 |  |  | 142,200 |  |  | $ | 0.07 |  |  |  | 9,463 |
ATM issue of shares No. 59 |  | 11 December 2024 |  |  | 522,100 |  |  | $ | 0.06 |  |  |  | 32,938 |
Alumni Equity Line of Credit |  | 16 December 2024 |  |  | 20,000,000 |  |  | $ | 0.04 |  |  |  | 874,939 |
ATM issue of shares No. 60 |  | 17 December 2024 |  |  | 6,421,800 |  |  | $ | 0.06 |  |  |  | 382,576 |
ATM issue of shares No. 61 |  | 02 January 2025 |  |  | 4,000,000 |  |  | $ | 0.03 |  |  |  | 128,729 |
ATM issue of shares No. 62 |  | 03 January 2025 |  |  | 2,939,500 |  |  | $ | 0.03 |  |  |  | 85,921 |
ATM issue of shares No. 63 |  | 06 January 2025 |  |  | 10,668,100 |  |  | $ | 0.03 |  |  |  | 305,565 |
ATM issue of shares No. 64 |  | 07 January 2025 |  |  | 2,453,900 |  |  | $ | 0.03 |  |  |  | 70,828 |
Maxim Warrants exercised |  | 30 January 2025 |  |  | 55,344,000 |  |  | $ | 0.02 |  |  |  | 988,042 |
Alumni Warrants exercised |  | 30 January 2025 |  |  | 55,334,000 |  |  | $ | 0.02 |  |  |  | 987,797 |
Perishing Warrants exercised |  |  | 30 January 2025 |  |  |  | 22,655,300 |  |  | $ | 0.02 |  |  |  | 404,432 |
Alumni Prefunded Warrants shares issued |  |  | 30 January 2025 |  |  |  | — |  |  | $ | — |  |  |  | 127 |
Alumni Equity Line of Credit |  |  | 11 February 2025 |  |  |  | 60,000,000 |  |  | $ | 0.02 |  |  |  | 917,450 |
Alumni Equity Line of Credit |  |  | 06 May 2025 |  |  |  | 15,000,000 |  |  | $ | 0.01 |  |  |  | 141,489 |
Alumni Equity Line of Credit |  |  | 06 June 2025 |  |  |  | 32,500,000 |  |  | $ | 0.02 |  |  |  | 504,043 |
Alumni Equity Line of Credit |  |  | 12 June 2025 |  |  |  | 35,000,000 |  |  | $ | 0.03 |  |  |  | 979,179 |
Alumni Equity Line of Credit |  |  | 18 June 2025 |  |  |  | 30,000,000 |  |  | $ | 0.02 |  |  |  | 599,674 |
Less: share issue transaction costs |  |  |  |  |  |  | — |  |  | $ | — |  |  |  | (712,515 | )
Balance |  |  | June 30, 2025 |  |  |  | 809,418,734 |  |  |  |  |  |  |  | 123,045,899 |
The ATM allows the Company to raise capital dynamically in the market, with no discount, no warrant coverage, and modest banking fees, allowing it to fund operations with minimal dilution to existing shareholders. An ATM with Oppenheimer & Co. Inc. (Oppenheimer) as sales agent was established in May 2022. Under the ATM, Kazia may offer and sell via Oppenheimer, in the form ofADSs, with each ADS representing 500 ordinary shares. Kazia entered into an Equity Distribution Agreement, dated as of 22 April 2022 (the “Sales Agreement”), with Oppenheimer, acting as sales agent for an initial capacity of US$35 million. On 4 September 2024, the Equity Distribution Agreement was amended to increase the aggregate offering price to US$50 million. During the year ended 30 June 2025 US$4,556,252 was drawn down from the ATM facility compared to US$1,656,016 for the year ended 30 June 2024. During fiscal year 2024, Kazia entered into a purchase agreement (the “Purchase Agreement”) with Alumni Capital LP (“Alumni Capital”). Pursuant to the Purchase Agreement, the Company may sell to Alumni Capital up to an aggregate of $15,000,000, of ADSs from time to time during the term of the Purchase Agreement. During the fiscal year ended 30 June 2025, Kazia sold an aggregate amount of A$5,638,016 of ADSs under the Purchase Agreement compared to A$776,264 for the year ended 30 June 2024. On 14 January 2025 the Company executed a direct offering with existing fundamental healthcare investor, Alumni Capital LP, of 1,333,333 of the Company’s ADSs (or ADS equivalents in lieu thereof), each ADS representing 100 ordinary shares of the Company, at a purchase price of US$ 1.50 per ADS (or ADS equivalent in lieu thereof) and concurrent private placement of unregistered warrants to purchase up to an aggregate of 1,333,333 ADSs. The warrants will have an exercise price of US$ 1.50 per ADS, will be immediately exercisable upon issuance, and will expire five and one-half years from the date of issuance. Additionally, on 14 January 2025, Maxim (broker) received 40,000 warrants - ex price $ 1.50 with an expiry of 14 July 2030. Further, Alumni Capital LP received 553,440 ADSs paying US$ 1.50 per ADS for a total of US$ 830,160 and received 779,893 pre-funded warrants with an ex-price of US$ 0.0001 paying US$ 1.4999 per prefunded warrant for a total of US$ 1,169,762.51 . All 779,893 warrants were exercised on 30 January 2025. After fees of $ 140,000 . were paid, the Company received US$ 1,860,000 . Ordinary shares Ordinary shares entitle the holder to participate in dividends and the proceeds on the winding up of the Company in proportion to the number of and amounts paid on the shares held. The fully paid ordinary shares have no par value and the Company does not have a limited amount of authorized capital. On a show of hands every member present at a meeting in person or by proxy shall have one vote and upon a poll each share shall have one vote. Share buy-back There is no current on-market share buy-back. Capital risk management The Consolidated Entity’s objectives when managing capital are to safeguard its ability to continue as a going concern so that it can provide returns for shareholders and benefits for other stakeholders and to maintain an optimum capital structure to reduce the cost of capital. Capital is regarded as total equity, as recognized in the statement of financial position, plus net debt. Net debt is calculated as total borrowings less cash and cash equivalents. The capital structure of the Consolidated Entity consists of cash and cash equivalents and equity attributable to equity holders. The overall strategy of the Consolidated Entity is to continue its drug development programs, which depends on raising sufficient funds, through a variety of sources including issuing of additional share capital, as may be required from time to time. The capital risk management policy remains unchanged from the prior year.

X
- Definition The disclosure of issued capital. [Refer: Issued capital] + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Note Expiry date 2027-01-01 -Name IAS -Number 1 -IssueDate 2025-01-01 -Paragraph 10 -Subparagraph e -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_10_e&doctype=Standard -URIDate 2025-03-27 + Details
Name: | ifrs-full_DisclosureOfIssuedCapitalExplanatory
Namespace Prefix: | ifrs-full_
Data Type: | dtr-2022:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | kzia_DisclosureAbstract
Namespace Prefix: | kzia_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration